Literature DB >> 8730950

The use of environmental strategies and psychotropic medication in the management of delirium.

D J Meagher1, D O'Hanlon, E O'Mahony, P R Casey.   

Abstract

BACKGROUND: This paper examines the pattern and frequency of implementation of environmental strategies and the use of psychotropic medication in the management of patients with delirium in an acute hospital setting.
METHOD: The study involved 46 consecutive referrals to a consultation psychiatry service each of whom met ICD-10 criteria for delirium. Patients were subdivided into hyperactive, hypoactive and mixed subtypes of delirium and assessed regarding severity of delirium, the use of psychotropic medication prior to consultation and the implementation of environmental measures in their management.
RESULTS: Mean age was 60.1 years. Thirty per cent of patients were of the hyperactive subtype, 24% hypoactive and 46% mixed. Psychotropic medication was given to 56.5% prior to consultation and this is significantly associated with severity of delirium and in particular, with hyperactive delirium subtype. Of eight environmental strategies only four were instituted in over 50% of the patients prior to consultation. The application of these strategies was associated with overall severity of delirium, agitation, mood lability and sleep-wake cycle disturbance. It was not significantly associated with severity of disorientation or with disturbed perception/thinking.
CONCLUSION: Simple environmental strategies such as limiting changes in staff, minimising noise levels and involving relatives in re-orientation are frequently overlooked in the management of patients with delirium. Our study suggests that the implementation of environmental strategies occurs primarily in responses to behavioural challenges rather than to limit the core features of delirium.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8730950     DOI: 10.1192/bjp.168.4.512

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  15 in total

Review 1.  Delirium: optimising management.

Authors:  D J Meagher
Journal:  BMJ       Date:  2001-01-20

Review 2.  Clinical pharmacology of old age syndromes.

Authors:  C Broadhurst; K C M Wilson; M T Kinirons; A Wagg; J K Dhesi
Journal:  Br J Clin Pharmacol       Date:  2003-09       Impact factor: 4.335

Review 3.  Treating an established episode of delirium in palliative care: expert opinion and review of the current evidence base with recommendations for future development.

Authors:  Shirley H Bush; Salmaan Kanji; José L Pereira; Daniel H J Davis; David C Currow; David Meagher; Kiran Rabheru; David Wright; Eduardo Bruera; Michael Hartwick; Pierre R Gagnon; Bruno Gagnon; William Breitbart; Laura Regnier; Peter G Lawlor
Journal:  J Pain Symptom Manage       Date:  2014-01-28       Impact factor: 3.612

Review 4.  Diagnosing and managing delirium in the elderly.

Authors:  D K Conn; S Lieff
Journal:  Can Fam Physician       Date:  2001-01       Impact factor: 3.275

Review 5.  Delirium in elderly adults: diagnosis, prevention and treatment.

Authors:  Tamara G Fong; Samir R Tulebaev; Sharon K Inouye
Journal:  Nat Rev Neurol       Date:  2009-04       Impact factor: 42.937

Review 6.  Delirium and its treatment.

Authors:  Azizah Attard; Gopinath Ranjith; David Taylor
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 7.  The pharmacologic management of delirium in children and adolescents.

Authors:  Susan Beckwitt Turkel; Alan Hanft
Journal:  Paediatr Drugs       Date:  2014-08       Impact factor: 3.022

8.  Delirium in elderly people: a review.

Authors:  Sónia Martins; Lia Fernandes
Journal:  Front Neurol       Date:  2012-06-19       Impact factor: 4.003

9.  Delirium and Agitation.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-03       Impact factor: 3.972

10.  Post-operative delirium after hip fracture treatment - a review of the current literature.

Authors:  Theocharis Chr Kyziridis
Journal:  Psychosoc Med       Date:  2006-02-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.